To validate the PC origin of the observed intestinal tumors, we bred Lyz1CreERT2 mice with R26LSL-tdTomato or R26LSL-YFP reporters and traced their lineage upon tamoxifen-driven targeting of the Apc, Kras and Trp53 mutations. The gene discussed is KRAS; the disease is intestinal neoplasm.